Beth M Beadle1, Kai-Ping Liao2, Sharon H Giordano2, Adam S Garden1, Katherine A Hutcheson3, Stephen Y Lai3, B Ashleigh Guadagnolo1. 1. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2. Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. 3. Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract
BACKGROUND: Intensity-modulated radiation therapy (IMRT) is a technologically advanced and resource-intensive method of delivering radiation therapy (RT) and is used to minimize toxicity for patients with head and neck cancer (HNC). Dependence on feeding tubes is a significant marker of toxicity of RT. The objective of this analysis was to compare the placement and duration of feeding tube use among patients with HNC from 1999 through 2011. METHODS: The cohort, demographics, and cancer-related variables were determined using the linked Surveillance, Epidemiology, and End Results (SEER)-Medicare database, and claims data were used to analyze treatment details. RESULTS: In total, 2993 patients were identified. At a median follow-up of 47 months, 54.4% of patients had ever had a feeding tube placed. The median duration from feeding tube placement to removal was 277 days. On zero-inflated negative binomial regression, patients who received IMRT and 3-dimensional RT (3DRT) (non-IMRT) had similar rates of feeding tube placement (odds ratio, 1.10; P = .35); however, patients who received 3DRT had a feeding tube in place 1.18 times longer than those who received IMRT (P = .03). The difference was only observed among patients who received definitive RT; patients who underwent surgery and also received adjuvant RT had no statistically significant difference in feeding tube placement or duration. CONCLUSIONS: Patients with HNC who received definitive IMRT had a significantly shorter duration of feeding tube placement than those who received 3DRT. These data suggest that there may be significant quality-of-life benefits to IMRT with respect to long-term swallowing function in patients with HNC. Cancer 2017;123:283-293.
BACKGROUND: Intensity-modulated radiation therapy (IMRT) is a technologically advanced and resource-intensive method of delivering radiation therapy (RT) and is used to minimize toxicity for patients with head and neck cancer (HNC). Dependence on feeding tubes is a significant marker of toxicity of RT. The objective of this analysis was to compare the placement and duration of feeding tube use among patients with HNC from 1999 through 2011. METHODS: The cohort, demographics, and cancer-related variables were determined using the linked Surveillance, Epidemiology, and End Results (SEER)-Medicare database, and claims data were used to analyze treatment details. RESULTS: In total, 2993 patients were identified. At a median follow-up of 47 months, 54.4% of patients had ever had a feeding tube placed. The median duration from feeding tube placement to removal was 277 days. On zero-inflated negative binomial regression, patients who received IMRT and 3-dimensional RT (3DRT) (non-IMRT) had similar rates of feeding tube placement (odds ratio, 1.10; P = .35); however, patients who received 3DRT had a feeding tube in place 1.18 times longer than those who received IMRT (P = .03). The difference was only observed among patients who received definitive RT; patients who underwent surgery and also received adjuvant RT had no statistically significant difference in feeding tube placement or duration. CONCLUSIONS:Patients with HNC who received definitive IMRT had a significantly shorter duration of feeding tube placement than those who received 3DRT. These data suggest that there may be significant quality-of-life benefits to IMRT with respect to long-term swallowing function in patients with HNC. Cancer 2017;123:283-293.
Authors: Julie L Locher; James A Bonner; William R Carroll; Jimmy J Caudell; Meredith L Kilgore; Christine S Ritchie; David L Roth; Gabriel S Tajeu; Ya Yuan; Jeroan J Allison Journal: Head Neck Date: 2011-05-20 Impact factor: 3.147
Authors: Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison Journal: J Clin Oncol Date: 2011-10-03 Impact factor: 44.544
Authors: Mihir K Bhayani; Katherine A Hutcheson; Denise A Barringer; Dianna B Roberts; Jan S Lewin; Stephen Y Lai Journal: Head Neck Date: 2013-01-16 Impact factor: 3.147
Authors: Mihir K Bhayani; Katherine A Hutcheson; Denise A Barringer; Asher Lisec; Clare P Alvarez; Dianna B Roberts; Stephen Y Lai; Jan S Lewin Journal: Head Neck Date: 2013-01-16 Impact factor: 3.147
Authors: Carrie N Klabunde; Julie M Legler; Joan L Warren; Laura-Mae Baldwin; Deborah Schrag Journal: Ann Epidemiol Date: 2007-05-25 Impact factor: 3.797
Authors: Joan L Warren; Angela Mariotto; Danielle Melbert; Deborah Schrag; Paul Doria-Rose; David Penson; K Robin Yabroff Journal: Med Care Date: 2016-08 Impact factor: 2.983
Authors: Katherine A Hutcheson; Zhannat Nurgalieva; Hui Zhao; Gary B Gunn; Sharon H Giordano; Mihir K Bhayani; Jan S Lewin; Carol M Lewis Journal: Head Neck Date: 2018-12-07 Impact factor: 3.147
Authors: Kristina R Dahlstrom; Juhee Song; Peter F Thall; Clifton D Fuller; Katherine A Hutcheson; Faye M Johnson; G Brandon Gunn; Jack Phan; Steven J Frank; William H Morrison; Renata Ferrarotto; David I Rosenthal; Erich M Sturgis; Adam S Garden Journal: Cancer Date: 2020-12-11 Impact factor: 6.860
Authors: R Martino; M I Fitch; C D Fuller; A Hope; G Krisciunas; S E Langmore; C Lazarus; C L Macdonald; T McCulloch; G Mills; D A Palma; K Pytynia; J Ringash; K Sultanem; J Theurer; K E Thorpe; K Hutcheson Journal: BMC Cancer Date: 2021-10-13 Impact factor: 4.430